TSNAX-DISC1: A Potential Drug Target and Biomarker (G100303453)

Target Name: TSNAX-DISC1

NCBI ID: G100303453

TSNAX-DISC1

Other Name(s): TSNAX-DISC1 readthrough (NMD candidate) | TSNAX-DISC1 readthrough (NMD candidate), transcript variant 1 | TSNAX-DISC1 variant 1

TSNAX-DISC1: A Potential Drug Target and Biomarker

Abstract:

TSNAX-DISC1, a protein expressed in various tissues and cell types, has been identified as a potential drug target and biomarker. Its unique structure and expression pattern across different tissues make it an attractive target for drug development. This article discusses the current understanding of TSNAX-DISC1, its potential drug target implications, and its potential as a biomarker for various diseases.

Introduction:

TSNAX-DISC1, short for tissue-specific nuclear factor of activating gene 1 (DNA-binding protein 1), is a protein that plays a crucial role in various cellular processes, including cell growth, differentiation, and inflammation. TSNAX-DISC1 is expressed in various tissues, including brain, heart, liver, and muscle, and has been associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Potential Drug Target:

TSNAX-DISC1 has been identified as a potential drug target due to its unique structure and expression pattern. TSNAX-DISC1 has a distinct N-terminus that is rich in conserved electrolytic features, including a negatively charged amino acid residue (D) and a positively charged amino acid residue (A). These features suggest that TSNAX-DISC1 may have unique electrostatic interactions with small molecules or other proteins, providing a potential target for drugs with altered activity. Additionally, its expression pattern across different tissues and cell types suggests that TSNAX-DISC1 may have different functions in different cell types, making it a potential drug target with unique effects.

Biomarker Potential:

TSNAX-DISC1 has been identified as a potential biomarker for various diseases due to its expression and function in different tissues. Its expression has been observed in various tissues, including brain, heart, liver, and muscle, making it a potential biomarker for these diseases. Additionally, its unique structure and expression pattern make it a potential biomarker for certain diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

Conclusion:

TSNAX-DISC1 is a protein that has the potential to be a drug target and biomarker. Its unique structure and expression pattern across different tissues make it an attractive target for drug development. Further research is needed to fully understand its functions and potential as a drug target and biomarker.

Protein Name: TSNAX-DISC1 Readthrough (NMD Candidate)

The "TSNAX-DISC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSNAX-DISC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets